<SEC-DOCUMENT>0001193125-22-159685-index.html : 20220525
<SEC-HEADER>0001193125-22-159685.hdr.sgml : 20220525
<ACCEPTANCE-DATETIME>20220525160727
ACCESSION NUMBER:		0001193125-22-159685
CONFORMED SUBMISSION TYPE:	S-3ASR
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20220525
DATE AS OF CHANGE:		20220525
EFFECTIVENESS DATE:		20220525

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ACADIA PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001070494
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				061376651
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3ASR
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-265205
		FILM NUMBER:		22962948

	BUSINESS ADDRESS:	
		STREET 1:		3611 VALLEY CENTRE DRIVE
		STREET 2:		SUITE 300
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		858-558-2871

	MAIL ADDRESS:	
		STREET 1:		3611 VALLEY CENTRE DRIVE
		STREET 2:		SUITE 300
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3ASR
<SEQUENCE>1
<FILENAME>d327934ds3asr.htm
<DESCRIPTION>S-3ASR
<TEXT>
Document 1 - file: d327934ds3asr.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d327934dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: d327934dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>d327934dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 3 - file: d327934dex231.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>d327934dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
Document 4 - file: d327934dexfilingfees.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g327934g01a02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g327934g01a02.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g327934g0524221651071.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: g327934g0524221651071.jpg

</DOCUMENT>
</SEC-DOCUMENT>